Ultime notizie per Jackson Finl (NYSE:JXN) Azioni

Jackson Finl

Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Wedbush analyst Michael Pachter upgrades AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) from Neutral to Outperform and raised the price target from $3 to $4. AMC Entertainment shares closed at $3.00 on Thursday. <a href="https://www.benzinga.com/quote/amc/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Asiya Merchant upgraded the rating for TE Connectivity plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEL#NYSE">TEL</a>) from Neutral to Buy and raised the price target from $150 to $200. TE Connectivity shares closed at $175.03 on Thursday. <a href="https://www.benzinga.com/quote/tel/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird analyst Luke Junk upgraded Visteon Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VC#NASDAQ">VC</a>) from Neutral to Outperform and boosted the price target from $96 to $125. Visteon shares closed at $108.29 on Thursday. <a href="https://www.benzinga.com/quote/vc/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen analyst Joshua Buchalter upgraded Texas Instruments Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) from Hold to Buy and raised the price target from $200 to $245. Texas Instruments shares closed at $219.66 on Thursday. <a href="https://www.benzinga.com/quote/txn/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Scotiabank analyst Sung Ji Nam upgraded the rating for Thermo Fisher Scientific Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) from Sector Perform to Sector Outperform and announced a $590 price target. Thermo Fisher Scientific shares closed at $430.73 on Thursday. <a href="https://www.benzinga.com/quote/tmo/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying TMO stock? Here&#8217;s what analysts think:
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="614" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11115238/image-136-1024x614.png" alt="" class="wp-image-982129" style="width:599px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11115238/image-136-1024x614.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11115238/image-136-300x180.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11115238/image-136-768x461.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11115238/image-136.png 1120w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46364472/top-3-real-estate-stocks-that-may-fall-off-a-cliff-this-month">Top 3 Real Estate Stocks That May Fall Off A Cliff This Month</a></li>
</ul>
Photo via Shutterstock

News

Upgrades

Intraday Update

Markets

Analyst Ratings

Trading Ideas

This Thermo Fisher Scientific Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

In a retail landscape increasingly dominated by fast fashion and digital-first brands, Levi Strauss &amp; Co&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) recent earnings report signals a noteworthy shift for traditional apparel companies aiming to <a href="https://www.benzinga.com/topic/retail">reclaim market relevance.</a>
Shares of Levi Strauss rallied in early trading on Friday after the company reported <a href="https://www.benzinga.com/markets/earnings/25/07/46356144/levi-strauss-shares-jump-on-q2-earnings-revenue-beat-raised-outlook" target="_blank" rel="noopener">upbeat second-quarter results on Thursday</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
JPMorgan On Levi Strauss
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586bcbd9351b9b0001ab738c/matthew-boss">Analyst Matthew Boss</a> reiterated an Overweight rating, while raising the price target from $18 to $23.
Levi Strauss reported adjusted earnings of 22 cents per share, beating the consensus of 14 cents per share, with 9% "broad-based" organic revenue growth and operating margins of 8.3% above Street expectations of 6.1%, Boss said in a note. "Importantly, +8.8% gross profit dollar growth in 2Q represented a +15% 2-year stack, which combined with ~50bps of SG&amp;A leverage translated to +35% YOY EPS growth," he wrote.
Management raised their full-year adjusted earnings guidance to $1.25-$1.30 per share, higher than the Street's $1.23 per share, the analyst stated. This shows that the company's gross profits in the second quarter more than offset the full-year tariff impact of 20 basis points, he added.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
BofA Securities On Levi Strauss
Analyst Christopher Nardone maintained a Buy rating, while raising the price target from $21 to $24.
Levi Strauss is "still in the early innings of a positive EPS revision cycle," and is poised to generate mid-single-digit sales growth and margin expansion ahead, Nardone said. The company reported a "clean" earnings beat, driven by higher sales and gross margin, he added.
This was the second consecutive quarter of high-single-digit organic sales growth, the analyst stated. The outlook for the back half of the year "could prove conservative given the momentum of the business if the macro environment holds," he further wrote.
LEVI Price Action: Levi Strauss shares were up 10.95% at $21.89 at the time of publication Friday, <a href="https://www.benzinga.com/pro/" target="_blank" rel="noreferrer noopener">according to Benzinga Pro</a>.
Read More:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46111337/micron-ceo-cautions-ai-boom-may-not-be-fully-sustainable-flags-tariff-driven-demand-pull-in"> BofA Securities Warns Tariffs Could Still Weigh On Retail Stocks Such As Gap, Ralph Lauren</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Earnings

Earnings Beats

Price Target

Reiteration

Movers

LEVI

Can Levi Strauss Keep Up Its Earnings Momentum?

Keefe, Bruyette &amp; Woods analyst Timothy Switzer maintains Bank of N.T Butterfield (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTB#NYSE">NTB</a>) with a Market Perform and raises the price target from $48 to $50.

Keefe, Bruyette & Woods Maintains Market Perform on Bank of N.T Butterfield, Raises Price Target to $50

Macro Economic Events

Global

Economics

Reuters Cites Saudi Energy Ministry Saying Marketed Crude Supply In June Stood At 9.352M Barrels/Day; Says While Production Briefly Exceeded Supply, The Additional Volumes Were Not Marketed Domestically Or Internationally But Redirected As Contingency Measure; Says Kingdom Reports Both Production And Supply Data With Full Transparency To The OPEC Secretariat On Monthly Basis

Reuters Cites Saudi Energy Ministry Saying It Confirms Saudi Arabia Has Remained Fully Compliant With Its Voluntary OPEC+ Target

Keefe, Bruyette &amp; Woods analyst Timothy Switzer maintains NewtekOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEWT#NASDAQ">NEWT</a>) with a Market Perform and lowers the price target from $13 to $12.

NEWT

Keefe, Bruyette & Woods Maintains Market Perform on NewtekOne, Lowers Price Target to $12

Keefe, Bruyette &amp; Woods analyst Timothy Switzer maintains Middlefield Banc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBCN#NASDAQ">MBCN</a>) with a Market Perform and raises the price target from $30 to $32.

MBCN

Keefe, Bruyette & Woods Maintains Market Perform on Middlefield Banc, Raises Price Target to $32

<a href="https://x.com/Alibaba_Qwen/status/1943692825566355819" title="https://x.com/Alibaba_Qwen/status/1943692825566355819">https://x.com/Alibaba_Qwen/status/1943692825566355819</a>

BABA

'Alibaba launches Qwen Chat for desktop. The new Qwen. ai platform offers three tools in one: Qwen Chat for brainstorming and creating, a Research section to keep up with Qwen's latest work, and the Qwen API to build your own AI-powered apps. The desktop version now supports MCP for smarter, faster agents and better productivity.'

Keefe, Bruyette &amp; Woods analyst Timothy Switzer maintains Live Oak Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOB#NYSE">LOB</a>) with a Market Perform and raises the price target from $34 to $36.

Keefe, Bruyette & Woods Maintains Market Perform on Live Oak Bancshares, Raises Price Target to $36

Scotiabank analyst Kevin Fisk maintains Parex Resources (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PXT#TSX">PXT</a>) with a Sector Perform and raises the price target from C$14 to C$16.

TSX:PXT

Scotiabank Maintains Sector Perform on Parex Resources, Raises Price Target to C$16

Keefe, Bruyette &amp; Woods analyst Catherine Mealor downgrades Hancock Whitney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWC#NASDAQ">HWC</a>) from Outperform to Market Perform and raises the price target from $62 to $63.

Downgrades

Keefe, Bruyette & Woods Downgrades Hancock Whitney to Market Perform, Raises Price Target to $63

Morningstar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MORN#NASDAQ">MORN</a>) has outperformed the market over the past 15 years by 26.02% on an annualized basis producing an average annual return of 38.47%. Currently, Morningstar has a market capitalization of $12.79 billion. 
Buying $100 In MORN: If an investor had bought $100 of MORN stock 15 years ago, it would be worth $13,244.82 today based on a price of $299.00 for MORN at the time of writing.
<h3>Morningstar's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752248718_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MORN

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

Keefe, Bruyette &amp; Woods analyst Timothy Switzer maintains Green Dot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDOT#NYSE">GDOT</a>) with a Market Perform and raises the price target from $11 to $12.

GDOT

Keefe, Bruyette & Woods Maintains Market Perform on Green Dot, Raises Price Target to $12

Keefe, Bruyette &amp; Woods analyst Catherine Mealor upgrades FB Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBK#NYSE">FBK</a>) from Market Perform to Outperform and raises the price target from $52 to $58.

Keefe, Bruyette & Woods Upgrades FB Financial to Outperform, Raises Price Target to $58

Keefe, Bruyette &amp; Woods analyst Kelly Motta maintains Customers Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBI#NYSE">CUBI</a>) with a Market Perform and raises the price target from $65 to $70.

CUBI

Keefe, Bruyette & Woods Maintains Market Perform on Customers Bancorp, Raises Price Target to $70

<a href="https://www.globenewswire.com/Tracker?data=1Hv_JrhYMWM9DUvj8H1p7vRcpU3ZVE9yhcTGdCgHIwHUwzxZhpY4EY0SxKXr7mPtNt6kJI5dlZDyLpxHva8Yse-oDPI6amtesfs4Sp4lr4Q=">Valneva SE</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALN#NASDAQ">VALN</a>, PARIS:<a class="ticker" href="https://www.benzinga.com/stock/VLA#PARIS">VLA</a>), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 years and above after concluding a thorough review of Valneva's single-dose chikungunya vaccine IXCHIQ&#xAE; by EMA's safety committee (PRAC).
The committee initiated its review at the beginning of May following the occurrence of serious side effects mainly in elderly people with several underlying medical conditions. In a press release published today on its website1, EMA underlined that the vaccine is already contraindicated for people with a weakened immune system and concluded that, for people of all ages, IXCHIQ&#xAE; should be given when there is a significant risk of chikungunya infection and after a careful consideration of the benefits and risks.
Additionally, EMA noted that while most serious side effects occurred in older people, IXCHIQ&#xAE; is effective at triggering the production of antibodies against the chikungunya virus which may be of particular benefit for older people who are at increased risk of severe chikungunya disease.
IXCHIQ&#xAE; was authorised in the European Union in June 20242 and, in March 2025, the European Commission granted a label extension in adolescents 12 years of age and older3.

Biotech

General

PARIS:VLA

VALN

Valneva's Chikungunya Vaccine IXCHIQ Cleared By European Medicines Agency For Use In Seniors After Safety Committee Review

Warren Buffett may still be <a href="https://www.benzinga.com/topic/warren-buffett">calling the shots in Omaha</a>, but the stock market appears to be pricing in a world without him &#8211; and fast.
During the second quarter of 2025, Berkshire Hathaway's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) Class B shares underperformed the S&amp;P 500 Index by a historic margin, lagging the benchmark by nearly 18 percentage points since the May 3rd shareholder meeting, when Buffett reiterated his retirement succession plan. 
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="1006" height="573" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11102807/Screenshot-2025-07-11-at-7.57.42-PM.png" alt="" class="wp-image-982001" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11102807/Screenshot-2025-07-11-at-7.57.42-PM.png 1006w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11102807/Screenshot-2025-07-11-at-7.57.42-PM-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11102807/Screenshot-2025-07-11-at-7.57.42-PM-768x437.png 768w" sizes="(max-width: 1006px) 100vw, 1006px" /></figure>
Source: TradingView
What makes this stretch remarkable isn't just the scale of the drop — it's that this is the biggest quarterly underperformance in the history of the stock, outside of the Covid crash (exception being the second quarter of 2020).
Read Also: <a href="https://www.benzinga.com/markets/equities/25/07/46313514/warren-buffetts-quiet-dividend-play-9-high-yield-stocks-held-by-a-berkshire-subsidiary">Warren Buffett&#8217;s Quiet Dividend Play: 9 High-Yield Stocks Held By A Berkshire Subsidiary</a>
<h2 class="wp-block-heading">This Isn't Just Another Rough Patch</h2>
Berkshire has had off quarters before, but rarely one this severe. In the second quarter of 2020, the market was in chaos, reacting violently to pandemic shutdowns, Fed shockwaves, and unprecedented global uncertainty.
In contrast, the second quarter of 2025 has been relatively stable and broadly bullish, with the S&amp;P 500 powering higher on AI euphoria, tech strength, and a resilient consumer.
So what's dragging Berkshire down? Likely, a mix of rotation out of value-heavy sectors, fading interest in financials and industrials, and a psychological shift as investors begin to think more tangibly about the post-Buffett era.
<h2 class="wp-block-heading">From Aura To Arithmetic</h2>
For decades, Berkshire traded with a halo &#8211; the &#8216;Buffett Premium&#8217; &#8211; a valuation lift rooted in investor faith in the Oracle's judgment and capital discipline. That premium now seems to be eroding. 
Without Buffett's active presence or new bold moves to counteract the market's pivot to growth and innovation, Berkshire is beginning to look like just another value stock.
And markets are treating it accordingly.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46109576/buffett-premium-fading-away-the-oracle-of-omahas-retirement-casts-shadow-on-berkshire-hathaways-stock-value-report">&#8216;Buffett Premium&#8217; Fading Away? The Oracle Of Omaha&#8217;s Retirement Casts Shadow On Berkshire Hathaway&#8217;s Stock Value: Report</a></li>
</ul>
Photo: Shutterstock

The Warren Buffett Premium May Finally Be Fading

Keefe, Bruyette &amp; Woods analyst Timothy Switzer maintains CNB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCNE#NASDAQ">CCNE</a>) with a Market Perform and raises the price target from $25 to $26.

CCNE

Keefe, Bruyette & Woods Maintains Market Perform on CNB Financial, Raises Price Target to $26

Keefe, Bruyette &amp; Woods analyst Timothy Switzer maintains Coastal Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCB#NASDAQ">CCB</a>) with a Outperform and raises the price target from $110 to $115.

Comments

Jackson Finl

Notizie

Ultime notizie per Jackson Finl (NYSE:JXN) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO